tachypnea

(redirected from sepsis syndrome)
Also found in: Thesaurus, Medical, Encyclopedia.

tach·yp·ne·a

 (tăk′ĭp-nē′ə, tăk′ĭ-nē′ə)
n.
Rapid breathing.

[New Latin : tachy- + Greek pnoiē, breathing (from pnein, to breathe; see pneu- in Indo-European roots).]

tach′yp·ne′ic adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

tachypnea, tachypnoea

abnormally rapid breathing or respiration.
See also: Disease and Illness
-Ologies & -Isms. Copyright 2008 The Gale Group, Inc. All rights reserved.
Translations

tach·y·pne·a

n. taquipnea, respiración rápida excesiva.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
The sepsis syndrome. Definition and general approach to management.
A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 1993;104(1):230-5.
(31) concluded that patients carrying sepsis syndrome criteria, TNF-[alpha], IL-1[beta] and IL-6 levels were high, and there was an inverse correlation between high IL-6 and survival regardless of microbiologic profiles.
Various terms have been used in reference to sepsis and its clinical presentations, including bacteremia, septicemia, sepsis, sepsis syndrome, and septic shock.
A study done by Vondra and Myres reported septic shock and acute sepsis syndrome in more than one-third of patients.
New insight into the pathogenesis of sepsis and the sepsis syndrome. Surgery 2005; 137: 393-5.
Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions.
Tsai et al., "Apoptotic adipose-derived mesenchymal stem cell therapy protects against lung and kidney injury in sepsis syndrome caused by cecal ligation puncture in rats," Stem Cell Research & Therapy, vol.
Silverman et al., "Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial.
Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock.
The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials.